Halsey Associates Inc. CT lessened its position in shares of Cerner Co. (NASDAQ:CERN) by 2.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 111,243 shares of the company’s stock after selling 3,295 shares during the quarter. Halsey Associates Inc. CT’s holdings in Cerner were worth $6,651,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CERN. Qube Research & Technologies Ltd increased its position in Cerner by 85.4% in the second quarter. Qube Research & Technologies Ltd now owns 2,898 shares of the company’s stock worth $173,000 after buying an additional 1,335 shares in the last quarter. Moneta Group Investment Advisors LLC grew its position in shares of Cerner by 3,608.5% during the second quarter. Moneta Group Investment Advisors LLC now owns 31,411 shares of the company’s stock worth $124,000 after purchasing an additional 30,564 shares in the last quarter. Zebra Capital Management LLC purchased a new stake in shares of Cerner during the second quarter worth about $929,000. Resources Investment Advisors Inc. grew its position in shares of Cerner by 4.3% during the second quarter. Resources Investment Advisors Inc. now owns 61,315 shares of the company’s stock worth $3,666,000 after purchasing an additional 2,522 shares in the last quarter. Finally, Tower Research Capital LLC TRC purchased a new stake in shares of Cerner during the second quarter worth about $326,000. Institutional investors own 76.08% of the company’s stock.

Several research firms recently issued reports on CERN. Canaccord Genuity increased their target price on Cerner from $64.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, August 3rd. Jefferies Financial Group set a $70.00 target price on Cerner and gave the stock a “buy” rating in a research report on Friday, June 1st. BidaskClub upgraded Cerner from a “sell” rating to a “hold” rating in a research report on Thursday, May 31st. ValuEngine upgraded Cerner from a “sell” rating to a “hold” rating in a research report on Saturday, June 16th. Finally, Stifel Nicolaus increased their target price on Cerner from $62.00 to $65.00 and gave the stock a “hold” rating in a research report on Wednesday, July 25th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $71.71.

In related news, Director Linda M. Dillman sold 3,900 shares of the stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $66.54, for a total transaction of $259,506.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Michael R. Battaglioli sold 4,000 shares of the stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $67.02, for a total value of $268,080.00. Following the transaction, the chief accounting officer now directly owns 2,226 shares of the company’s stock, valued at $149,186.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,270,870 shares of company stock valued at $82,486,031. 4.71% of the stock is owned by corporate insiders.

Shares of Cerner stock opened at $64.94 on Friday. Cerner Co. has a 12 month low of $52.05 and a 12 month high of $73.86. The company has a market cap of $21.31 billion, a P/E ratio of 29.52, a PEG ratio of 2.05 and a beta of 0.97. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.85 and a quick ratio of 2.83.

Cerner (NASDAQ:CERN) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $0.62 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.02. Cerner had a return on equity of 15.26% and a net margin of 16.06%. The company had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the company earned $0.61 earnings per share. The firm’s revenue was up 5.9% on a year-over-year basis. research analysts predict that Cerner Co. will post 2.28 earnings per share for the current year.

Cerner Profile

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Further Reading: Dow Jones Industrial Average (DJIA)

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.